[27-62-pm1] Synthesis (incl. Total synthesis) 4

[27-62-pm1-07] Structural development of the anti-HBV active compound (E)-CFCP; Synthesis of acyclic derivatives and evaluation of antiviral activities.

○HIROKI KUMAMOTO¹, NOBUYO HIGASHI KUWATA², Natsumi TAKAHASHI¹, SYOMEI SHU¹, RYUKI ASO¹, RENA NARIDUKA¹, KAZUHIRO HARAGUCHI¹, HIROAKI MITSUYA^2,3 (1. Nihon Pharmaceutical University, 2. National Center of Global Medicine , 3. NIH)